Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB

Summary: Mucopolysaccharidoses (MPSs) are lysosomal disorders with neurological involvement for which no cure exists. Here, we show that recombinant NK1 fragment of hepatocyte growth factor rescues substrate accumulation and lysosomal defects in MPS I, IIIA and IIIB patient fibroblasts. We investiga...

Full description

Bibliographic Details
Main Authors: Melania Scarcella, Gianluca Scerra, Mariangela Ciampa, Marianna Caterino, Michele Costanzo, Laura Rinaldi, Antonio Feliciello, Serenella Anzilotti, Chiara Fiorentino, Maurizio Renna, Margherita Ruoppolo, Luigi Michele Pavone, Massimo D’Agostino, Valeria De Pasquale
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224001809
_version_ 1797319437074825216
author Melania Scarcella
Gianluca Scerra
Mariangela Ciampa
Marianna Caterino
Michele Costanzo
Laura Rinaldi
Antonio Feliciello
Serenella Anzilotti
Chiara Fiorentino
Maurizio Renna
Margherita Ruoppolo
Luigi Michele Pavone
Massimo D’Agostino
Valeria De Pasquale
author_facet Melania Scarcella
Gianluca Scerra
Mariangela Ciampa
Marianna Caterino
Michele Costanzo
Laura Rinaldi
Antonio Feliciello
Serenella Anzilotti
Chiara Fiorentino
Maurizio Renna
Margherita Ruoppolo
Luigi Michele Pavone
Massimo D’Agostino
Valeria De Pasquale
author_sort Melania Scarcella
collection DOAJ
description Summary: Mucopolysaccharidoses (MPSs) are lysosomal disorders with neurological involvement for which no cure exists. Here, we show that recombinant NK1 fragment of hepatocyte growth factor rescues substrate accumulation and lysosomal defects in MPS I, IIIA and IIIB patient fibroblasts. We investigated PI3K/Akt pathway, which is of crucial importance for neuronal function and survival, and demonstrate that PI3K inhibition abolishes NK1 therapeutic effects. We identified that autophagy inhibition, by Beclin1 silencing, reduces MPS IIIB phenotype and that NK1 downregulates autophagic-lysosome (ALP) gene expression, suggesting a possible contribution of autophagosome biogenesis in MPS. Indeed, metabolomic analyses revealed defects of mitochondrial activity accompanied by anaerobic metabolism and inhibition of AMP-activated protein kinase (AMPK), which acts on metabolism and autophagy, rescues lysosomal defects. These results provide insights into the molecular mechanisms of MPS IIIB physiopathology, supporting the development of new promising approaches based on autophagy inhibition and metabolic rewiring to correct lysosomal pathology in MPSs.
first_indexed 2024-03-08T04:06:52Z
format Article
id doaj.art-b7dab594af994d1eb4614b3cad83d1e6
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-03-08T04:06:52Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-b7dab594af994d1eb4614b3cad83d1e62024-02-09T04:48:54ZengElsevieriScience2589-00422024-03-01273108959Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIBMelania Scarcella0Gianluca Scerra1Mariangela Ciampa2Marianna Caterino3Michele Costanzo4Laura Rinaldi5Antonio Feliciello6Serenella Anzilotti7Chiara Fiorentino8Maurizio Renna9Margherita Ruoppolo10Luigi Michele Pavone11Massimo D’Agostino12Valeria De Pasquale13Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy; CEINGE Biotecnologie Avanzate Franco Salvatore, Via G. Salvatore 486, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy; CEINGE Biotecnologie Avanzate Franco Salvatore, Via G. Salvatore 486, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, ItalyDepartment of Science and Technology, University of Sannio, Via F. de Sanctis, 82100 Benevento, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy; CEINGE Biotecnologie Avanzate Franco Salvatore, Via G. Salvatore 486, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy; Corresponding authorDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy; Corresponding authorDepartment of Veterinary Medicine and Animal Productions, University of Naples Federico II, Via F. Delpino 1, 80137 Naples, Italy; Corresponding authorSummary: Mucopolysaccharidoses (MPSs) are lysosomal disorders with neurological involvement for which no cure exists. Here, we show that recombinant NK1 fragment of hepatocyte growth factor rescues substrate accumulation and lysosomal defects in MPS I, IIIA and IIIB patient fibroblasts. We investigated PI3K/Akt pathway, which is of crucial importance for neuronal function and survival, and demonstrate that PI3K inhibition abolishes NK1 therapeutic effects. We identified that autophagy inhibition, by Beclin1 silencing, reduces MPS IIIB phenotype and that NK1 downregulates autophagic-lysosome (ALP) gene expression, suggesting a possible contribution of autophagosome biogenesis in MPS. Indeed, metabolomic analyses revealed defects of mitochondrial activity accompanied by anaerobic metabolism and inhibition of AMP-activated protein kinase (AMPK), which acts on metabolism and autophagy, rescues lysosomal defects. These results provide insights into the molecular mechanisms of MPS IIIB physiopathology, supporting the development of new promising approaches based on autophagy inhibition and metabolic rewiring to correct lysosomal pathology in MPSs.http://www.sciencedirect.com/science/article/pii/S2589004224001809Human metabolismCell biology
spellingShingle Melania Scarcella
Gianluca Scerra
Mariangela Ciampa
Marianna Caterino
Michele Costanzo
Laura Rinaldi
Antonio Feliciello
Serenella Anzilotti
Chiara Fiorentino
Maurizio Renna
Margherita Ruoppolo
Luigi Michele Pavone
Massimo D’Agostino
Valeria De Pasquale
Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB
iScience
Human metabolism
Cell biology
title Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB
title_full Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB
title_fullStr Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB
title_full_unstemmed Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB
title_short Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB
title_sort metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis iiib
topic Human metabolism
Cell biology
url http://www.sciencedirect.com/science/article/pii/S2589004224001809
work_keys_str_mv AT melaniascarcella metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT gianlucascerra metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT mariangelaciampa metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT mariannacaterino metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT michelecostanzo metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT laurarinaldi metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT antoniofeliciello metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT serenellaanzilotti metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT chiarafiorentino metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT mauriziorenna metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT margheritaruoppolo metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT luigimichelepavone metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT massimodagostino metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib
AT valeriadepasquale metabolicrewiringandautophagyinhibitioncorrectlysosomalstoragediseaseinmucopolysaccharidosisiiib